Dosage Forms
Form | Route | Strength |
---|---|---|
Capsule | Oral | 250 mg |
Capsule | Oral | 500 mg |
Capsule | 250 mg | |
Capsule, coated | Oral | 250 mg |
Capsule, coated | Oral | 542 mg |
Powder, for suspension | Oral | 2.,5 g |
Powder; syrup | Oral | 62.5 mg/5mL |
Powder, for suspension | Oral | 125 mg |
Powder, for suspension | Oral | 2500 mg |
Powder, for suspension | Oral | 5 g |
Powder, for suspension | Oral | 5.41 g |
Powder, for solution | Oral | 5.7375 g |
Capsule, coated | Oral | 500 mg |
Suspension | Oral | 2.,5 g |
Capsule | Oral | 250 mg/1 |
Capsule | Oral | 500 mg/1 |
Suspension | Oral | 5 g |
Tablet, coated | Oral | 250 mg |
Powder, for suspension | Oral | 62.,5 mg/5mL |
Powder; syrup | Oral | 125 mg/5mL |
Prices
Unit description | Cost | Unit |
---|---|---|
Dicloxacillin Sodium 500 mg capsule | 1.25USD | capsule |
Dicloxacillin 500 mg capsule | 1.2USD | capsule |
Dicloxacillin Sodium 250 mg capsule | 0.,69USD | capsule |
Dicloxacillin 250 mg capsule | 0.66USD | capsule |
DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.
Patents Not Available
Properties
State Solid Experimental Properties
Property | Value | Source |
---|---|---|
water solubility | 3.,63 mg/L | Not Available |
logP | 2.91 | HANSCH,C ET AL. (1995) |
Predicted Properties
Property | Value | Source |
---|---|---|
Water Solubility | 0.0296 mg/mL | ALOGPS |
logP | 3.19 | ALOGPS |
logP | 2.91 | ChemAxon |
logS | -4.,2 | ALOGPS |
pKa (Strongest Acidic) | 3.75 | ChemAxon |
pKa (Strongest Basic) | -0.71 | ChemAxon |
Physiological Charge | -1 | ChemAxon |
Hydrogen Acceptor Count | 5 | ChemAxon |
Hydrogen Donor Count | 2 | ChemAxon |
Polar Surface Area | 112.74 Å2 | ChemAxon |
Rotatable Bond Count | 3 | ChemAxon |
Refractivity | 111.,44 m3·mol-1 | ChemAxon |
Polarizability | 42., | ChemAxon |
Rule of Five | Yes | ChemAxon |
Ghose Filter | Yes | ChemAxon |
Veber’s Rule | No | ChemAxon |
MDDR-like Rule | No | ChemAxon |
Predicted ADMET Features
Property | Value | Probability |
---|---|---|
Human Intestinal Absorption | + | 0.,8368 |
Blood Brain Barrier | – | 0.9903 |
Caco-2 permeable | – | 0.8957 |
P-glycoprotein substrate | Non-substrate | 0.6204 |
P-glycoprotein inhibitor I | Non-inhibitor | 0.8951 |
P-glycoprotein inhibitor II | Non-inhibitor | 0.9204 |
Renal organic cation transporter | Non-inhibitor | 0.9629 |
CYP450 2C9 substrate | Non-substrate | 0.,8262 |
CYP450 2D6 substrate | Non-substrate | 0.905 |
CYP450 3A4 substrate | Substrate | 0.5977 |
CYP450 1A2 substrate | Inhibitor | 0.8592 |
CYP450 2C9 inhibitor | Non-inhibitor | 0.891 |
CYP450 2D6 inhibitor | Non-inhibitor | 0.918 |
CYP450 2C19 inhibitor | Non-inhibitor | 0.8832 |
CYP450 3A4 inhibitor | Non-inhibitor | 0.,819 |
CYP450 inhibitory promiscuity | Low CYP Inhibitory Promiscuity | 0.9186 |
Ames test | Non AMES toxic | 0.6979 |
Carcinogenicity | Carcinogens | 0.5672 |
Biodegradation | Not ready biodegradable | 1.0 |
Rat acute toxicity | 1.9946 LD50, mol/kg | Not applicable |
hERG inhibition (predictor I) | Weak inhibitor | 0.,9996 |
hERG inhibition (predictor II) | Non-inhibitor | 0.8486 |
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties.,>
Prezis LC-MS/MS
Nu este Disponibil
Prezis de MS/MS Spectru – 10V, Negative (Adnotate)
Prezis LC-MS/MS
Nu este Disponibil
Prezis de MS/MS Spectru – 20V, Negative (Adnotate)
Prezis LC-MS/MS
Nu este Disponibil
Prezis de MS/MS Spectru – 40V, Negative (Adnotate)
Prezis LC-MS/MS
Nu este Disponibil
Obiective
un Fel de Proteine Organismului Listeria monocytogenes serotip 4b str., LL195 Pharmacological action
Yes
Actions
Inhibitor
General Function Not Available Specific Function Penicillin binding Gene Name pbpC Uniprot ID A0A0E1R3H3 Uniprot Name Penicillin-binding protein 3 Molecular Weight 75015.58 Da
- Gutkind GO, Ogueta SB, de Urtiaga AC, Mollerach ME, de Torres RA: Participation of PBP 3 in the acquisition of dicloxacillin resistance in Listeria monocytogenes. J Antimicrob Chemother. 1990 May;25(5):751-8.,
Kind Protein Organism Streptococcus pneumoniae (strain ATCC BAA-255 / R6) Pharmacological action
Yes
Actions
Inhibitor
General Function Transferase activity, transferring acyl groups Specific Function Not Available Gene Name pbp1b Uniprot ID Q7CRA4 Uniprot Name Penicillin-binding protein 1b Molecular Weight 89479.92 Da
- Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae., Antimicrob Agents Chemother. 1980 Oct;18(4):629-37.
Kind Protein Organism Streptococcus pneumoniae (strain ATCC BAA-255 / R6) Pharmacological action
Yes
Actions
Inhibitor
General Function Transferase activity, transferring acyl groups Specific Function Not Available Gene Name pbp2a Uniprot ID Q8DNB6 Uniprot Name Penicillin-binding protein 2a Molecular Weight 80797.,94 Da
- Williamson R, Hakenbeck R, Tomasz A: interacțiunea in vivo a antibioticelor beta-lactamice cu proteinele care leagă penicilina de Streptococcus pneumoniae. Agenți Antimicrob Chemother. 1980 Octombrie; 18 (4): 629-37.,
Kind Protein Organism Streptococcus pneumoniae Pharmacological action
Yes
Actions
Inhibitor
General Function Serine-type d-ala-d-ala carboxypeptidase activity Specific Function Not Available Gene Name pbp3 Uniprot ID Q75Y35 Uniprot Name Penicillin-binding protein 3 Molecular Weight 45209.84 Da
- Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother., 1980 Oct;18(4):629-37.
Kind Protein Organism Streptococcus pneumoniae (strain ATCC BAA-255 / R6) Pharmacological action
Yes
Actions
Inhibitor
General Function Penicillin binding Specific Function Cell wall formation. Gene Name pbpA Uniprot ID Q8DR59 Uniprot Name Penicillin-binding protein 1A Molecular Weight 79700.9 Da
- Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae., Antimicrob Agents Chemother. 1980 Oct;18(4):629-37.
Kind Protein Organism Streptococcus pneumoniae (strain ATCC BAA-255 / R6) Pharmacological action
Yes
Actions
Inhibitor
General Function Not Available Specific Function Penicillin binding Gene Name penA Uniprot ID P0A3M6 Uniprot Name Penicillin-binding protein 2B Molecular Weight 73872.,305 Da
- Williamson R, Hakenbeck R, Tomasz A: In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980 Oct;18(4):629-37.
Enzymes
Kind Protein Organism Humans Pharmacological action
Unknown
Actions
Inducer
General Function Vitamin d3 25-hydroxylase activity Specific Function Cytochromes P450 are a group of heme-thiolate monooxygenases., În microzomii hepatici, această enzimă este implicată într-o cale de transport a electronilor dependentă de NADPH. Se efectuează o varietate de oxidare reacționează… Nume de Gene CYP3A4 Uniprot ID P08684 Uniprot Numele Citocromului P450 3A4 Greutate Moleculară 57342.67 Da
- Yasuda K, Ranade O, Venkataramanan R, Strom S, Chupka J, Ekins S, Schuetz E, Bachmann K: Un amplu in vitro și in silico analiza de antibiotice, care activa pregnane X receptor și induce CYP3A4 în ficat și intestin. Droguri Metab Dispos. 2008 Aug; 36 (8): 1689-97. doi: 10.1124/dmd.108.020701. Epub 2008 Mai 27.,>
Transporters
Binding Properties
×
Property | Measurement | pH | Temperature (°C) | |
---|---|---|---|---|
Ki (nM) | 7200000 | N/A | N/A | 15567297 / 15974593 |
Details
Binding Properties1., Familia transportatorului de solut 15 membru 1
Tip proteină organism om Acțiune farmacologică
necunoscut
acțiuni
Inhibitor
funcția generală oligopeptidă dependentă de protoni activitate secundară activă transportor transmembranar funcție specifică aport cuplat de protoni de oligopeptide de 2 până la 4 aminoacizi cu preferință pentru dipeptide. Poate constitui o cale majoră pentru absorbția produselor finale de digestie proteică. Numele genei SLC15A1 UNIPROT ID P46059 numele Uniprot familia transportatorului solut 15 membru 1 Greutate moleculară 78805.,265 Da
- Luckner P, Brandsch M: Interacțiunea de 31 de antibiotice beta-lactamice cu H+/peptide symporter PEPT2: analiza de afinitate constante și în comparație cu PEPT1. Eur J Pharm Biopharm. 2005 ianuarie;59 (1): 17-24.,
Binding Properties
×
Property | Measurement | pH | Temperature (°C) | |
---|---|---|---|---|
Ki (nM) | 420000 | N/A | N/A | 21741846 |
Details
Binding Properties2., Solut purtător de familie 15 state 2
un Fel de Proteine Organismului Oameni acțiune Farmacologică
Necunoscut
Acțiuni
Inhibitor
General Funcția de Peptide:proton symporter activitate Specifice Funcției de Protoni-cuplat aportul de oligopeptide de la 2 la 4 aminoacizi cu o preferință pentru dipeptide. Numele genei SLC15A2 ID-ul Uniprot Q16348 numele Uniprot familia transportatorului solut 15 membru 2 Greutate moleculară 81782.,77 Da
- Luckner P, Brandsch M: Interacțiunea de 31 de antibiotice beta-lactamice cu H+/peptide symporter PEPT2: analiza de afinitate constante și în comparație cu PEPT1. Eur J Pharm Biopharm. 2005 ianuarie;59 (1): 17-24.
×
Imbunatati rezultatele pacient
Construi eficiente instrumente de suport decizional cu industria cea mai cuprinzătoare de droguri-droguri de interacțiune checker.,
Aflați mai multe
medicament creat pe 13 iunie 2005 07:24 / actualizat pe 07 Ianuarie 2021 17:57
0